Remedy (REMEDY) CMD 2024 summary
Event summary combining transcript, slides, and related documents.
CMD 2024 summary
21 Sep, 2026Strategic direction and future plans
Entering a new era of sustainable, profitable growth in 2025, with regular annual game launches and expansion of existing franchises into world-class entertainment properties.
Four strategic pillars: grow world-class franchises, make distinctive category-leading games, enable successful productions, and self-publish owned games.
Focus on expanding Alan Wake and Control through sequels, spin-offs, and transmedia opportunities, leveraging partnerships for TV/film adaptations.
Max Payne Remake serves as a partner franchise project, balancing the portfolio and utilizing synergies.
Portfolio management emphasizes efficiency, synergy, and alignment, with no significant headcount growth planned.
Financial guidance and targets
Plans to double 2024 revenue by 2027, with continued growth targeted beyond that milestone.
Targets an EBITDA margin of 30% by 2027 and to maintain at least this level through 2030.
Minimum 100% return on investment per game, with business cases built for 3–5 year payback periods.
Self-publishing expected to significantly increase profit potential compared to previous publisher-funded models.
Funding secured through cash reserves and a €15 million convertible loan from Tencent.
Business model and self-publishing transition
Transitioning from development fees and royalties to a revenue model dominated by self-published game sales.
Self-publishing enables greater financial upside, closer integration between development and publishing, and more direct audience engagement.
Publishing team expanded to over 18 people, with further selective hiring planned; operational scale achieved via key external partners.
Marketing budgets for AAA launches are managed carefully, with flexibility for post-launch investment, especially for multiplayer/service games.
Risks in self-publishing include marketing effectiveness and competition, mitigated by strong partnerships and systematic audience research.
Latest events from Remedy
- Q2 revenue fell 40%, but CONTROL Resonant's strong pre-launch momentum drives optimism.REMEDY
Q2 2026 - Profitable Q1 with strong game sales, CONTROL Resonant focus, and positive 2026 outlook.REMEDY
Q1 2026 - 2025 revenue rose 17.5% to €59.5M, with CONTROL Resonant set for 2026 launch.REMEDY
Q4 2025 - Q3 revenue dropped 32% and a major impairment led to a sharp EBIT loss despite cash gains.REMEDY
Q3 2025 - Q2 revenue up 64% to EUR 16.9M; Firebreak launch underwhelms, but outlook stays positive.REMEDY
Q2 2025 - Q3 2024 revenue up 129%, fueled by development fees, partnerships, and self-publishing shift.REMEDY
Q3 2024 - Revenue up 33.7%, Q2 up 16.2%, profitability improves, and key franchises advance.REMEDY
Q2 2024 - Revenue up 24.1%, profitability restored, and first self-published title launches in June.REMEDY
Q1 2025 - Revenue up 49% in 2024; self-publishing and partnerships drive growth and profitability.REMEDY
Q4 2024